Liquidia, GSK in drug delivery deal

Liquidia Technologies Inc. (Research Triangle Park, N.C.) granted GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) exclusive, worldwide rights to develop certain vaccines and inhaled products using Liquidia's ...